Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States.
- Authors
- Croghan, Ivana T; Hurt, Richard D; Ebbert, Jon O; Croghan, Gary A; Polk, Octavius D; Stella, Philip J; Novotny, Paul J; Sloan, Jeff; Loprinzi, Charles L
- Year
- 2010
- Journal
- Zeitschrift fur Gesundheitswissenschaften = Journal of public health
- PMID
- 21088690
- DOI
- 10.1007/s10389-009-0277-2
- PMCID
- PMC2967232
BACKGROUND: This study evaluates differences in smoking abstinence between white and minority smokers using pharmaceutical aids. METHODS: This is an analysis of data from a multi-center, randomized, clinical trial conducted in the United States. Of the 1,684 subjects randomized to one of three medications (nicotine inhaler, bupropion, or a combination of both), 60% were women and 10% were minority races. RESULTS: Factors associated with a decreased likelihood of smoking at 12 weeks were older age (OR = 0.971, p < 0.0001), being married (OR = 0.678, p = 0.0029), using bupropion SR (OR = 0.480, p < 0.0001), and using combination therapy (OR = 0.328, p < 0.0001). Factors associated with an increased likelihood of smoking were higher tobacco dependence scores (OR = 1.244, p < 0.0001), prior quit attempts (OR = 1.812, p = 0.004), and being a minority (OR = 1.849, p = 0.0083). Compared to white smokers, minority smokers were significantly older at time of study entry (46 vs. 42 years, p < 0.0001), less likely to be married (35% vs. 59%, p < 0.0001), older at smoking initiation (21 vs. 19 years of age, p < 0.0001), and had a lower abstinence rate (16% vs. 26%, p = 0.0065). CONCLUSION: Regardless of the treatment used, minority smokers in the US have lower smoking abstinence after treatment for tobacco dependence. Future research should focus on the improvement in treatment strategies for minority smokers.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. | 2012 | 22648373 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Representativeness of Electronic Referral to Smoking Treatment Trials in Adult Primary Care. | Kim N et al. | — | 2025 | → |
| A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer. | Gittleman J et al. | — | 2024 | → |
| Antidepressants for smoking cessation. | Hajizadeh A et al. | — | 2023 | → |
| Association of racial discrimination in health care settings and use of electronic cigarettes to quit smoking among Black adults. | Jackson AB et al. | — | 2023 | → |
| Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial. | Nollen NL et al. | — | 2021 | → |
| Antidepressants for smoking cessation. | Howes S et al. | — | 2020 | → |
| Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study. | Nollen NL et al. | — | 2019 | → |
| A review of the effects of nicotine on social functioning. | Martin LM et al. | — | 2018 | → |
| Nicotine replacement therapy versus control for smoking cessation. | Hartmann-Boyce J et al. | — | 2018 | → |
| Relative contribution of genetic, individual, and self-efficacy factors to smoking cessation in a Chinese rural population. | Wang Q et al. | — | 2017 | → |
| A clinical trial to examine disparities in quitting between African-American and White adult smokers: Design, accrual, and baseline characteristics. | Nollen NL et al. | — | 2016 | → |
| Gender, Ethnicity, and Their Intersectionality in the Prediction of Smoking Outcome Expectancies in Regular Cigarette Smokers. | Aguirre CG et al. | — | 2016 | → |
| Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. | Kumar P et al. | — | 2016 | → |
| Black Cigarette Smokers Report More Attention to Smoking Cues Than White Smokers: Implications for Smoking Cessation. | Robinson CD et al. | — | 2015 | → |
| A systematic review of nicotine by inhalation: is there a role for the inhaled route? | Caldwell B et al. | — | 2012 | → |
| Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. | Chen LS et al. | — | 2012 | → |
| Nicotine replacement therapy for smoking cessation. | Stead LF et al. | — | 2012 | → |
| Tobacco dependence counseling in a randomized multisite clinical trial. | Croghan IT et al. | — | 2012 | → |
| A pilot clinical trial of varenicline for smoking cessation in black smokers. | Nollen NL et al. | — | 2011 | → |